Priority Date: 02.04.10 (US 20100320398P)

GENE-BASED PREDICTION OF PSA RECURRENCE FOR CLINICALLY LOCALIZED PROSTATE CANCER PATIENTS

  • Application ID: EP11763422
  • Status: NO OPPOSITION FILED WITHIN TIMELIMIT

Applicant

Technology company logo small
Technology Company

Attorney

Employment test 51 - 200 employees
Company dna carpmarls and ransford
operating since 1848
Headquarter in London and 2 offices
active in Legal Services and IP Consulting

Specialization

This EP application has the IPC class C12 (BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING) and G01 (MEASURING; TESTING). We found, that TransMIT GmbH, Kailuweit & Uhlemann, Weidner Stern Jeschke, dompatent von Kreisler Selting Werner - Partnerschaft von Patent- und Rechtsanwälten mbB, Avidity IP Ltd and 98 others are specialized in this combination either. For a similar patent, they might be a good choice.

Timeline

  • 02.04.2010 - Priority Date (US 20100320398P)
  • 06.10.2011 - Publication A1 (WO2011123615)
  • 06.02.2013 - Publication A1 (EP2553445)
  • 30.03.2016 - Publication B1 (EP2553445)

IPC Classification